Company Filing History:
3 out of 174 
1 out of 11 Years Active: 1999-2004
Title: Chikao Nakayama: Innovator in Neurotrophic Factors
Introduction
Chikao Nakayama is a prominent inventor based in Sanda, Japan. He has made significant contributions to the field of neurotrophic factors, particularly in the development of therapeutic agents for diabetes and neurodegenerative diseases. With a total of 4 patents, Nakayama's work has the potential to impact the treatment of various health conditions.
Latest Patents
One of Nakayama's latest patents is focused on Modified BDNF (brain-derived neurotrophic factor). This innovation involves modifying BDNF with a 1-acyl-glycerol derivative to enhance its pharmacological activities, pharmacokinetics, and physical properties. The modified BDNF demonstrates improved efficacy and pharmacokinetic properties while retaining the beneficial effects characteristic of BDNF. This makes it particularly useful as a therapeutic agent for the treatment of type 2 diabetes mellitus and neurodegenerative diseases.
Another significant patent addresses the use of hepatocyte growth factor for the treatment of diabetes. This therapeutic agent is designed to treat diabetes and hyperlipemia, especially type II diabetes mellitus. It comprises neurotrophic factors such as BDNF and ligands of trkB or trkC receptors. Unlike conventional oral hypoglycemic agents, this innovative agent exhibits blood lipid regulating effects and body fat accumulation regulating effects, thereby reducing risk factors associated with diabetes, hyperlipemia, and obesity.
Career Highlights
Chikao Nakayama has worked with notable companies in the pharmaceutical industry, including Sumitomo Pharmaceuticals Company Limited and Ltt Bio-pharma Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Throughout his career, Nakayama has collaborated with esteemed colleagues such as Hiroshi Noguchi and Mutsuo Taiji. These collaborations have further enriched his research and development efforts in the field of neurotrophic factors.
Conclusion
Chikao Nakayama's contributions to the field of neurotrophic factors and diabetes treatment highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to advancing medical science and providing new therapeutic options for patients.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.